This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acquisition Of Greenway Medical Technologies, Inc. By Vitera Healthcare Solutions, LLC May Not Be In The Best Interests Of Greenway Medical Technologies, Inc. Shareholders

SAN DIEGO and CARROLLTON, Ga., Sept. 24, 2013 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Greenway Medical Technologies, Inc. (NYSE: GWAY) by Vitera Healthcare Solutions, LLC.  On September 23, 2013, Greenway announced the signing of a definitive merger agreement under which Vitera Healthcare Solutions, an affiliate of Vista Equity Partners, will acquire Greenway in an all cash transaction for $20.35 per share.  The Greenway board of directors has unanimously approved the agreement.  Vitera Healthcare Solutions will commence a cash tender officer to purchase all outstanding shares of common stock, which is expected to close in the fourth quarter of 2013.


Is the Merger Best for Greenway and Its Shareholders?

Robbins Arroyo LLP's investigation focuses on whether the board of directors at Greenway is undertaking a fair process to obtain maximum value and adequately compensate its shareholders in the merger.  As an initial matter, the $20.35 consideration represents a premium of just 20.06% based on Greenway's closing price on September 20, 2013.  This premium is substantially below the median one-day premium of 35.59% for comparable transactions in the last three years.     

Further, on August 19, 2013, Greenway announced the company's earnings for its fourth quarter 2013, reporting revenue of $134.8 million for its fiscal year 2013, an increase of $10.8 million compared to its same period 2012.  Further, the company reported that revenue from recurring sources accounted for 57.6% of revenue for the fiscal fourth quarter 2013, compared to the 43.8% of revenue for the same quarter 2012.  Reflecting on the significance of the increase in revenue from recurring sources, Tee Green, president and chief executive officer of Greenway, stated, "Our results for the fourth quarter and full year reflect an organization that is successfully reducing its reliance on one-time sales and increasing revenue from more predictable recurring sources while introducing a platform that is gaining increased acceptance among those providers we serve…We are encouraged by the continued strong growth of revenue from recurring sources of 28% during our fiscal fourth quarter, when compared to the prior year, and the substantial improvement in overall revenue mix from predictable sources."

Given these facts, Robbins Arroyo is examining Greenway's board of directors' decision to sell the company to Vitera Healthcare Solutions now rather than allow shareholders to continue to participate in the company's continued success and future growth prospects, and whether they are seeking to benefit themselves.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,815.93 +3.74 0.02%
S&P 500 2,089.09 -0.05 -0.00%
NASDAQ 5,108.22 +5.4120 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs